参考文献

1.郭卫.中华骨科学·骨肿瘤卷.北京:人民卫生出版社，2010: 1-6

2.Schajowicz F.Tumors and tumorlike lesion of bone.2nd ed.New York: Springer-Verlag，1996: 185-220

3.Campanacci M.Bone and soft tissue tumors.New York: springer-verlag，1990: 87-120

4.Unni KK.Dahlin’s bone tumors.5thed.Philadelphia: Lippicott-Raven，1996: 56-78n

5.Parkin DM，Bray F，Ferlay J，et al.Global cancer statistics，2002.CA Cancer J Clin，2005，55(2): 74-108

6.PoweU CA，Spira A，Derti A，et al.Gene expression in lung adenocarcinomas of smok-ers and nonsmokers.Am J Respir Cell Mol Biol，2003，29(2): 157-162

7.Bailey-Wilson JE，Amos CI，Pinney SM，et al.A major lung cancer susceptibility locus maps to chromosome 6q23-25.Am J Hum Genet，2004，75(3): 460-474

8.Yoon KA，Kim JH，Gil HJ，et al.CYP1B1，CYP1A1，MPO，and GSTP1 polymorp-hisms and lung cancer risk in neversmoking Korean women.Lung Cancer，2008，60(1): 40-46

9.Hu CP.Advances on epidemiology of lung cancer and tobacco control.Chin J Lung Cancer，2008，11(1): 25-28

10.LI J，WANG Z，KUANG YK.Advances of Molecular Etiology on Lung Cancer in N on Smokers.Chin J Lung Cancer，2009，12(5): 357-360

11.Walsh T，Casadei S，Coats KH，et al.Spectrum of mutations in BRCA1，BRCA2，CHEK2 and TP53 in families at high risk of breast cancer.JAMA，2006，295(12): 1379-1388

12.Song CG.Hu Z，Wu J，et al.The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer.J Cancer Res Clin Oncol，2006，132(10): 617-626

13.Cotterchio M，Boucher BA，Kreiger N，et al.Dietary phytoestrogen intake-lignans andisoflavones and breast cancer risk(Canada).Cancer Causes Control，2008.19(3): 259-272

14.Travis RC，Allen NE，Appleby PN，et al.A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women.Int J Cancer，2007，122(3): 705-710

15.Lichrenstein P，holm NV，Verkasalo PK，et al.Environment and heritable factors in the causation of Cancer: analysis of cohort of twins from Sweden.denmark，and fin-land.N Eng I J，2002，343: 78-85

16.Jemal A，Siegel R，Ward E，et al.Cancer statistics，2010.CA Cancer J Clin，2011，61: 133-134

17.Chen M，Huang YC，Yang S，et al.Common variants at 8q24 are associated with prostate cancer risk in Taiwanese men.Prostate，2010，70: 502-507

18.Liu M，Wang J，Xu Y，et al.Risk loci on chromosome 8q24 are associated with prostate cancer in northern chinese men.J Urol，2012，187: 315-321

19.Wang M，Liu F，Hsing AW，et al.Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the China PCa consortium.Carcinogenesis Advance.Carcinogenesis，2012，33: 356-360

20.Jemal A，Siegel R，Ward E，et al.Cancer statistics，2009.CA Cancer J Clin，2009，59: 225-249

21.Anderas F，Melinda S，Lilly W，et al.Bone metastases from renal cell carcinoma: pat-entsurvival after surgical treatment.BMC Musculoskeletal Disorder，2010，11，145

22.Kusuda Y，Miyake H，Behnsawy HM，et al.Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecul markers in radical nephrectomy specimens.Urologic Oncology，2013，31(1): 42-50

23.Shinh R，Masuyer E，Ferlay J，et al.Cancer in Asia-Incidence rates based on data in cancer incidence in five cintinents I X(1998-2002).Asia pac J Cancer Prev，2010，11 Supple2: 11-16

24.Jung KW，Park S，Kong HJ，et al.Cancer statistics in Korea: incidence，mortality，sur-vival，and prevalence in 2008.Cancer Res Treat，2011，43: 1-11

25.E1-Osta H.Falchook G，Tsimberidou A，et al.BRAF mutations in advanced cancers: clinical characteristics and outcomes.J PLoS One，2011，6(10): e25806